Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin

Inclusion Criteria: * 19\~55 years healthy male * BMI measurement 19.0kg/m\^2\~ 28.0kg/m\^2 * Signed informed consent form from to participate voluntarily and to comply with the trial requirements. Exclusion Criteria: * History of clinically significant kidney, liver, gastro-intestinal system, cardiovascular system, respiratory system, tumor or blood disorders, nervous system, immune system, endocrine disorders, cardiovascular diseases, mental disorders (mood disorders, obsessive-compulsive disorder, etc.) * SBP\>140mmHg or \<90mmHg, DBP\>90mmHg or \<60mmHg. * An impossible one who participants in clinical trial by investigator's decision including laboratory test result or another reason. * History of drug abuse * A alcohol consumer(alcohol\>140g/week) or smoker(cigarette\>10 cigarettes/day) Hypersensitivity reaction in history of investigational drugs or specific drugs(aspirin, antibiotics) * Administrated investigational product in a previous clinical trial within 60 days of the screening day in this study. * Administrated drugs which can inhibit or induce OCT2, OATP1B1 transporter within 30 days of the screening day in this study.(ex: proton pump inhibitor, rifampicin) * Glomerular filtration rate\<60mL/min * Donated blood within 60 days prior to the screening day or apheresis blood within 30 days prior to the screening day .